Presentation

DIOMED (Transnational cooperation for technological innovation in the development of molecules for the treatment of diabetes and obesity) is focusing on drug development for the treatment of diabetes and obesity.

Project execution: 36 months

Starting date: 1.04.2009

End date: 31.03.2012

Project code: SOE1/P1/E178

ERDF funding: 813.673,43€

Project cost: 1.084.897,91€

National funding: 271.224,48€ 

Operational Program priority no. 1: promotion of innovation and setting up of stable networks of technological cooperation.

FAQ's DIOMED: Check our frequent questions and answers about the project (Includes a Glossary of project terms)